Table 3 Sensitivity to cisplatin, cetuximab and radiation

Cell line

IC₅₀ (μmol/L)^a

E_max (%)^a

ID₅₀ (Gy)^a

LU-HNSCC-26

0.99 (0.89–1.1)

18 (17–19)

0.90 (0.85–0.95)

LU-HNSCC-4

10 (9.0–11)

29 (27–32) ^b

16 (15–17)

LU-HNSCC-5

20 (19–22)

74 (68–80) ^b

19 (18–21)

LU-HNSCC-6

24 (23–26)

51 (43–60) ^b

23 (22–25)